XML 24 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net loss $ (64,209) $ (118,762)
Adjustments to reconcile net loss to net cash used in operating activities:    
Changes in fair value of warrant liabilities (1,218) 86,378
Depreciation and amortization 591 213
Loss on induced exchanges of debt 0 13,005
Amortization of deferred revenue (94) (17)
Amortization of bond premiums 3 (14)
Amortization of debt issuance costs 36 1,569
Amortization of deferred rent 109 (9)
(Decrease) increase in allowance for doubtful accounts 0 3
Non-cash expense related to stock compensation 1,734 584
Changes in operating assets and liabilities 13,396 (3,520)
Net cash used in operating activities (49,652) (20,570)
Cash flows from investing activities    
Purchases of marketable securities 0 (245)
Proceeds from sales/maturities of marketable securities 21,818 15,124
Purchases of property and equipment (3,184) (789)
Net cash provided by investing activities 18,634 14,090
Cash flows from financing activities:    
Exercise of stock options 131 612
Exercise of warrants 375 0
Sale of common stock and warrants, net of related expenses 0 5,906
Direct cost of raising equity 0 (419)
Tax withholding payments for stock compensation (167) (51)
Net cash provided by financing activities 339 6,048
Effect of changes in exchange rates on cash, cash equivalents and restricted cash 4 (2)
Net decrease in cash, cash equivalents and restricted cash (30,675) (434)
Cash, cash equivalents and restricted cash beginning of period 612,582 43,393
Cash, cash equivalents and restricted cash end of period 581,907 42,959
Supplemental disclosure of cash flow information:    
Interest paid 475 2,375
Schedule for non-cash investing and financing activities:    
Issuance of common shares for debt conversion 0 80,000
Accrued capital expenditures 2,449 0
Shares received in cashless exercise 634 0
Non-cash component of warrant exercise 1,776 11,242
Total cash, cash equivalents and restricted cash $ 612,582 $ 43,393